NEOGEN Neogen Chemicals Q2 FY27 results (Jul–Sep 2026) and concall
Neogen Chemicals delivered a strong Q2 FY27 with consolidated revenue surging 42% YoY to INR 296 crore and EBITDA rising 51% YoY to INR 45 crore, driven by robust volume expansion in core specialty chemicals and an accelerating ramp-up in battery materials. The company strengthened its balance sheet by raising INR 600 crore via a maiden QIP and accepting an additional INR 152 crore insurance settlement for the Dahej facility. Management reaffirmed an optimistic medium-term outlook, targeting FY28 battery chemicals revenue of over INR 1,000 crore and FY29 battery segment revenue of INR 2,500 to
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY27: revenue up 457.1%, net profit up 133.3% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22 | -3 | 5 | 7 | 8 −64% | 22 +833% | 37 +640% | 39 +457% |
| EBITDA | 38 | 41 | 35 | 35 | 36 −5% | 45 +10% | 48 +37% | 54 +54% |
| Net profit | 14 | 5 | 14 | 9 | 9 −36% | 15 +200% | 19 +36% | 21 +133% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
